Literature DB >> 10417278

Molecular characterization of CTNS deletions in nephropathic cystinosis: development of a PCR-based detection assay.

L Forestier1, G Jean, M Attard, S Cherqui, C Lewis, W van't Hoff, M Broyer, M Town, C Antignac.   

Abstract

Nephropathic cystinosis is an autosomal recessive disorder that is characterized by accumulation of intralysosomal cystine and is caused by a defect in the transport of cystine across the lysosomal membrane. Using a positional cloning strategy, we recently cloned the causative gene, CTNS, and identified pathogenic mutations, including deletions, that span the cystinosis locus. Two types of deletions were detected-one of 9.5-16 kb, which was seen in a single family, and one of approximately 65 kb, which is the most frequent mutation found in the homozygous state in nearly one-third of cystinotic individuals. We present here characterization of the deletion breakpoints and demonstrate that, although both deletions occur in regions of repetitive sequences, they are the result of nonhomologous recombination. This type of mechanism suggests that the approximately 65-kb deletion is not a recurrent mutation, and our results confirm that it is identical in all patients. Haplotype analysis shows that this large deletion is due to a founder effect that occurred in a white individual and that probably arose in the middle of the first millenium. We also describe a rapid PCR-based assay that will accurately detect both homozygous and heterozygous deletions, and we use it to show that the approximately 65-kb deletion is present in either the homozygous or the heterozygous state in 76% of cystinotic patients of European origin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417278      PMCID: PMC1377934          DOI: 10.1086/302509

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  15 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

2.  Fine mapping of the cystinosis gene using an integrated genetic and physical map of a region within human chromosome band 17p13.

Authors:  G McDowell; T Isogai; A Tanigami; S Hazelwood; D Ledbetter; M H Polymeropoulos; U Lichter-Konecki; D Konecki; M M Town; W V Van't Hoff; J Weissenbach; W A Gahl
Journal:  Biochem Mol Med       Date:  1996-08

3.  Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population.

Authors:  N Risch; D de Leon; L Ozelius; P Kramer; L Almasy; B Singer; S Fahn; X Breakefield; S Bressman
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

4.  A comprehensive genetic map of the human genome based on 5,264 microsatellites.

Authors:  C Dib; S Fauré; C Fizames; D Samson; N Drouot; A Vignal; P Millasseau; S Marc; J Hazan; E Seboun; M Lathrop; G Gyapay; J Morissette; J Weissenbach
Journal:  Nature       Date:  1996-03-14       Impact factor: 49.962

5.  Identification and detection of the common 65-kb deletion breakpoint in the nephropathic cystinosis gene (CTNS).

Authors:  Y Anikster; C Lucero; J W Touchman; M Huizing; G McDowell; V Shotelersuk; E D Green; W A Gahl
Journal:  Mol Genet Metab       Date:  1999-02       Impact factor: 4.797

6.  High-resolution mapping of the gene for cystinosis, using combined biochemical and linkage analysis.

Authors:  G Jean; A Fuchshuber; M M Town; O Gribouval; J A Schneider; M Broyer; W van't Hoff; P Niaudet; C Antignac
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

7.  Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A.

Authors:  D Lakich; H H Kazazian; S E Antonarakis; J Gitschier
Journal:  Nat Genet       Date:  1993-11       Impact factor: 38.330

8.  Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis.

Authors:  W A Gahl; N Bashan; F Tietze; I Bernardini; J D Schulman
Journal:  Science       Date:  1982-09-24       Impact factor: 47.728

9.  Nonhomologous recombination in the human genome: deletions in the human factor VIII gene.

Authors:  P Woods-Samuels; H H Kazazian; S E Antonarakis
Journal:  Genomics       Date:  1991-05       Impact factor: 5.736

10.  Alport syndrome and diffuse leiomyomatosis: deletions in the 5' end of the COL4A5 collagen gene.

Authors:  C Antignac; J Zhou; M Sanak; P Cochat; B Roussel; G Deschênes; F Gros; B Knebelmann; M C Hors-Cayla; K Tryggvason
Journal:  Kidney Int       Date:  1992-11       Impact factor: 10.612

View more
  34 in total

1.  Evaluation of topical cysteamine therapy in the CTNS(-/-) knockout mouse using in vivo confocal microscopy.

Authors:  Jennifer L Simpson; Chyong Jy Nien; Kevin J Flynn; James V Jester
Journal:  Mol Vis       Date:  2011-10-08       Impact factor: 2.367

2.  Infantile Nephropathic Cystinosis: A Novel CTNS Mutation.

Authors:  Hakan Doneray; Mohammed Aldahmesh; Gulsah Yilmaz; Emine Cinici; Zerrin Orbak
Journal:  Eurasian J Med       Date:  2017-06

3.  Clinical utility gene card for: cystinosis.

Authors:  Elena Levtchenko; Lambertus van den Heuvel; Francesco Emma; Corinne Antignac
Journal:  Eur J Hum Genet       Date:  2013-09-18       Impact factor: 4.246

4.  Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter.

Authors:  V Kalatzis; S Cherqui; C Antignac; B Gasnier
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

5.  Next generation sequencing as second-tier test in high-throughput newborn screening for nephropathic cystinosis.

Authors:  Tobias Fleige; Siegfried Burggraf; Ludwig Czibere; Julia Häring; Birgit Glück; Lisa Marie Keitel; Olfert Landt; Erik Harms; Katharina Hohenfellner; Jürgen Durner; Wulf Röschinger; Marc Becker
Journal:  Eur J Hum Genet       Date:  2019-09-30       Impact factor: 4.246

6.  Cystinosis as a lysosomal storage disease with multiple mutant alleles: Phenotypic-genotypic correlations.

Authors:  Mohammad Al-Haggar
Journal:  World J Nephrol       Date:  2013-11-06

7.  A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety.

Authors:  Craig B Langman; Larry A Greenbaum; Minnie Sarwal; Paul Grimm; Patrick Niaudet; Georges Deschênes; Elisabeth Cornelissen; Denis Morin; Pierre Cochat; Debora Matossian; Segolene Gaillard; Mary Jo Bagger; Patrice Rioux
Journal:  Clin J Am Soc Nephrol       Date:  2012-05-03       Impact factor: 8.237

Review 8.  New aspects of the pathogenesis of cystinosis.

Authors:  Vasiliki Kalatzis; Corinne Antignac
Journal:  Pediatr Nephrol       Date:  2003-02-27       Impact factor: 3.714

Review 9.  Nonequilibrium thermodynamics of thiol/disulfide redox systems: a perspective on redox systems biology.

Authors:  Melissa Kemp; Young-Mi Go; Dean P Jones
Journal:  Free Radic Biol Med       Date:  2007-11-28       Impact factor: 7.376

10.  Late-onset nephropathic cystinosis: clinical presentation, outcome, and genotyping.

Authors:  Aude Servais; Vincent Morinière; Jean-Pierre Grünfeld; Laure-Hélène Noël; Jean-Michel Goujon; Bernadette Chadefaux-Vekemans; Corinne Antignac
Journal:  Clin J Am Soc Nephrol       Date:  2008-01       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.